SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike proteinEduardo A. Albornoz, Trent M. Woodruff, Alberto A. Amarilla et al.|Molecular Psychiatry|2022Cited by 178
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA virusesAlberto A. Amarilla, Alexander A. Khromykh, Joshua M. Hardy et al.|Nature Communications|2021Cited by 177
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathologyJulio Aguado, Ernst J. Wolvetang, Alberto A. Amarilla et al.|Nature Aging|2023Cited by 70
An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2Alberto A. Amarilla, Daniel Watterson, Naphak Modhiran et al.|Frontiers in Microbiology|2021Cited by 69
No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencingNathan Smits, Geoffrey J. Faulkner, Jay Rasmussen et al.|Cell Reports|2021Cited by 52